Thompson Siegel & Walmsley LLC Moderna, Inc. Transaction History

Thompson Siegel & Walmsley LLC

  • $6.24 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
BUY
$118.38 - $210.04 $16,928 - $30,035
143 New
143 $25,000
Q1 2022

Apr 26, 2022
SELL
$126.46 - $235.05 $13,531 - $25,150
-107 Reduced 42.8%
143 $25,000
Q3 2021

Nov 05, 2021
BUY
$221.9 - $484.47 $55,475 - $121,117
250 New
250 $96,000

Others Institutions Holding MRNA

# of Institutions
1,113
Shares Held
241M
Call Options Held
9.26M
Put Options Held
12.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email